Application of Mesoporous Silica Nanoparticle-Chitosan-Loaded BMP-2 in the Repair of Bone Defect in Chronic Osteomyelitis

Overview

Journal J Immunol Res

Publisher Wiley

Specialty Allergy & Immunology

Date 2022 Aug 12

PMID 35958879

Authors

Min Yi

Yu Nie

Chengyun Zhang

Bin Shen

Affiliations

Soon will be listed here.

Abstract

In order to test the effectiveness of nanoparticle- (NP-) loaded bone morphogenetic protein 2 (BMP-2) in chronic osteomyelitis (CO) complicated with bone defect, a new nanodrug delivery system composed of mesoporous silica NP (MSN) and chitosan were used to load BMP-2 and transfer it to the target region. Bone marrow mesenchymal stem cells (BMSCs) were purchased and cultivated to detect the osteogenesis of chitosan-MSN (Chi-MSN) and polylactic acid glycolic acid (PLGA) delivery system. In addition, the osteogenesis of Chi-MSN was further determined by constructing a bone defect mouse model. In physicochemical property test, we found Chi-MSN NPs could effectively maintain stability in vivo and had pH response characteristics. As a result, the release efficiency of dexamethasone (Dex) and BMP-2 in the environment with pH 7.4 was less, while it increased significantly in pH 6, so as to reduce the BMP-2 and Dex loss during transportation in vivo. Otherwise, we found that the permeation efficiency of Chi-MSN was significantly higher than that of PLGA delivery system, so as to effectively transport BMP-2 and Dex to action target. In the BMSC test, we found that Chi-MSN could better promote their activity and osteogenesis, and the expression of osteogenesis-related genes (runt-related transcription factor 2 (RUNX-2), osteopontine (OPN), alkaline phosphatase (ALP), and osteopontine (OCN)) in the Chi-MSN group was higher. In the bone defect mouse model test, we also found obviously increased bone trabecula number and thickness by Chi-MSN, contributing to better repair of bone defects. Therefore, BMP-2@Chi-MSN may be a better choice for the therapy of CO complicated with bone defect in the future.

Citing Articles

The Expression Level of Inflammation-Related Genes in Patients With Bone Nonunion and the Effect of BMP-2 Infected Mesenchymal Stem Cells Combined With nHA/PA66 on the Inflammation Level of Femoral Bone Nonunion Rats.

Huang Y, Zhang Q, Jing Q, Li X, Dong F Physiol Res. 2024; 73(5):819-829.

PMID: 39560192 PMC: 11629945. DOI: 10.33549/physiolres.935439.

Comparison of different hydroxyapatite composites for bone tissue repair: and analyses.

Su X, Si X, Liu Y, Xiong N, Li S, Tang L Iran J Basic Med Sci. 2024; 27(9):1155-1161.

PMID: 39055877 PMC: 11266744. DOI: 10.22038/IJBMS.2024.78578.16995.

Recent advances of nanoparticles on bone tissue engineering and bone cells.

Zhang G, Zhen C, Yang J, Wang J, Wang S, Fang Y Nanoscale Adv. 2024; 6(8):1957-1973.

PMID: 38633036 PMC: 11019495. DOI: 10.1039/d3na00851g.

Advances of Antimicrobial Peptide-Based Biomaterials for the Treatment of Bacterial Infections.

Li G, Lai Z, Shan A Adv Sci (Weinh). 2023; 10(11):e2206602.

PMID: 36722732 PMC: 10104676. DOI: 10.1002/advs.202206602.

Current research progress of local drug delivery systems based on biodegradable polymers in treating chronic osteomyelitis.

Liu Y, Li X, Liang A Front Bioeng Biotechnol. 2022; 10:1042128.

PMID: 36507256 PMC: 9729283. DOI: 10.3389/fbioe.2022.1042128.

References

Venkatesan J, Vinodhini P, Sudha P, Kim S . Chitin and chitosan composites for bone tissue regeneration. Adv Food Nutr Res. 2014; 73:59-81. DOI: 10.1016/B978-0-12-800268-1.00005-6. View

Flores-Arriaga J, de Jesus Pozos-Guillen A, Gonzalez-Ortega O, Escobar-Garcia D, Masuoka-Ito D, Del Campo-Tellez B . Calcium sustained release, pH changes and cell viability induced by chitosan-based pastes for apexification. Odontology. 2018; 107(2):223-230. DOI: 10.1007/s10266-018-0389-7. View

Ouyang Z, Tan T, Zhang X, Wan J, Zhou Y, Jiang G . LncRNA ENST00000563492 promoting the osteogenesis-angiogenesis coupling process in bone mesenchymal stem cells (BMSCs) by functions as a ceRNA for miR-205-5p. Cell Death Dis. 2020; 11(6):486. PMC: 7316863. DOI: 10.1038/s41419-020-2689-4. View

Croissant C, Gounou C, Bouvet F, Tan S, Bouter A . Trafficking of Annexins during Membrane Repair in Human Skeletal Muscle Cells. Membranes (Basel). 2022; 12(2). PMC: 8877144. DOI: 10.3390/membranes12020153. View

Cao M, Zhou Y, Mao J, Wei P, Chen D, Wang R . Promoting osteogenic differentiation of BMSCs via mineralization of polylactide/gelatin composite fibers in cell culture medium. Mater Sci Eng C Mater Biol Appl. 2019; 100:862-873. DOI: 10.1016/j.msec.2019.02.079. View

Saeed H, Iqtedar M . Bone Marrow Stromal Cell (BMSC) and skeletal aging: role of telomerase enzyme. Pak J Pharm Sci. 2014; 27(2):321-33. View

Rahimi S, Khoee S, Ghandi M . Development of photo and pH dual crosslinked coumarin-containing chitosan nanoparticles for controlled drug release. Carbohydr Polym. 2018; 201:236-245. DOI: 10.1016/j.carbpol.2018.08.074. View

Stepniewski M, Martynkiewicz J, Gosk J . Chitosan and its composites: Properties for use in bone substitution. Polim Med. 2017; 47(1):49-53. DOI: 10.17219/pim/76517. View

Kou D, Du M, Hou X, Chen B, Li X, Fang Y . Centimeter-sized biomimetic bone constructs fabricated via CBD-BMP2-collagen microcarriers and BMSC-gelatin microspheres. J Mater Chem B. 2020; 4(3):461-470. DOI: 10.1039/c5tb02048d. View

10.

Liao L, Shi B, Chang H, Su X, Zhang L, Bi C . Heparin improves BMSC cell therapy: Anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy. Theranostics. 2017; 7(1):106-116. PMC: 5196889. DOI: 10.7150/thno.16911. View

11.

Kozusko S, Riccio C, Goulart M, Bumgardner J, Jing X, Konofaos P . Chitosan as a Bone Scaffold Biomaterial. J Craniofac Surg. 2018; 29(7):1788-1793. DOI: 10.1097/SCS.0000000000004909. View

12.

Dong M, Jiao G, Liu H, Wu W, Li S, Wang Q . Biological Silicon Stimulates Collagen Type 1 and Osteocalcin Synthesis in Human Osteoblast-Like Cells Through the BMP-2/Smad/RUNX2 Signaling Pathway. Biol Trace Elem Res. 2016; 173(2):306-15. DOI: 10.1007/s12011-016-0686-3. View

13.

Cox A, Zhao Y, Ferguson P . Chronic Recurrent Multifocal Osteomyelitis and Related Diseases-Update on Pathogenesis. Curr Rheumatol Rep. 2017; 19(4):18. PMC: 5545929. DOI: 10.1007/s11926-017-0645-9. View

14.

Akahane M, Shimizu T, Kira T, Onishi T, Uchihara Y, Imamura T . Culturing bone marrow cells with dexamethasone and ascorbic acid improves osteogenic cell sheet structure. Bone Joint Res. 2016; 5(11):569-576. PMC: 5131089. DOI: 10.1302/2046-3758.511.BJR-2016-0013.R1. View

15.

Liu Y, Ming L, Luo H, Liu W, Zhang Y, Liu H . Integration of a calcined bovine bone and BMSC-sheet 3D scaffold and the promotion of bone regeneration in large defects. Biomaterials. 2013; 34(38):9998-10006. DOI: 10.1016/j.biomaterials.2013.09.040. View

16.

Conterno L, Turchi M . Antibiotics for treating chronic osteomyelitis in adults. Cochrane Database Syst Rev. 2013; (9):CD004439. PMC: 11322802. DOI: 10.1002/14651858.CD004439.pub3. View

17.

Hassanzadeh P, Atyabi F, Dinarvand R . The significance of artificial intelligence in drug delivery system design. Adv Drug Deliv Rev. 2019; 151-152:169-190. DOI: 10.1016/j.addr.2019.05.001. View

18.

Wang Y, Mostafa N, Hsu C, Rose L, Kucharki C, Yan J . Modification of human BMSC with nanoparticles of polymeric biomaterials and plasmid DNA for BMP-2 secretion. J Surg Res. 2013; 183(1):8-17. DOI: 10.1016/j.jss.2012.11.061. View

19.

Birhanu G, Tanha S, Javar H, Seyedjafari E, Zandi-Karimi A, Kiani Dehkordi B . Dexamethasone loaded multi-layer poly-l-lactic acid/pluronic P123 composite electrospun nanofiber scaffolds for bone tissue engineering and drug delivery. Pharm Dev Technol. 2018; 24(3):338-347. DOI: 10.1080/10837450.2018.1481429. View

20.

Zhao Y, Ferguson P . Chronic Nonbacterial Osteomyelitis and Chronic Recurrent Multifocal Osteomyelitis in Children. Pediatr Clin North Am. 2018; 65(4):783-800. DOI: 10.1016/j.pcl.2018.04.003. View